» Articles » PMID: 35620166

Sex-specific Lipid Dysregulation in the Knockout Mouse Brain

Overview
Journal Brain Commun
Specialty Neurology
Date 2022 May 27
PMID 35620166
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease is a devastating neurodegenerative disease that affects more women than men. The pathomechanism underlying the sex disparity, especially in the brain, is unclear. is one of the strongest susceptibility genes for Alzheimer's disease. It mediates the transport of lipids across membranes and is associated with pathways related to amyloid-β neuropathology. However, the role of ABCA7 in the regulation of brain lipids is largely unknown. Sex-specific differences in the pathological link between brain lipid dysregulation and amyloid-β are also unknown. Here, we undertook quantitative discovery lipidomics of male and female knockout ( = 52) and wild type ( = 35) mouse brain using sophisticated liquid chromatography/mass spectrometry. We identified 61 lipid subclasses in the mouse brain and found sex-specific differences in lipids that were altered with deletion. The altered lipids belong to cellular pathways that control cell signalling, sterol metabolism, mitochondrial function and neuroprotection. We also investigated the relationship between lipids and amyloid-β levels in the knockout mice and found elevated free cholesterol only in female mice that was significantly correlated with amyloid-β42 levels. In male knockout mice, the neuroprotective ganglioside GD1a levels were elevated and inversely correlated with amyloid-β42 levels. Collectively, these results demonstrate that deletion leads to sex-specific lipid dysregulation in the brain, providing insight into the underlying sex disparity in the aetiology of Alzheimer's disease.

Citing Articles

The ABC transporter A7 modulates neuroinflammation via NLRP3 inflammasome in Alzheimer's disease mice.

Santos-Garcia I, Bascunana P, Brackhan M, Villa M, Eiriz I, Bruning T Alzheimers Res Ther. 2025; 17(1):30.

PMID: 39871385 PMC: 11773842. DOI: 10.1186/s13195-025-01673-2.


The Abca7 variant reduces Aβ generation, plaque load, and neuronal damage.

Butler C, Mendoza Arvilla A, Milinkeviciute G, Da Cunha C, Kawauchi S, Rezaie N Alzheimers Dement. 2024; 20(7):4914-4934.

PMID: 38506634 PMC: 11247689. DOI: 10.1002/alz.13783.


Nanopore Long-Read Sequencing Unveils Genomic Disruptions in Alzheimer's Disease.

Ramirez P, Sun W, Dehkordi S, Zare H, Pascarella G, Carninci P bioRxiv. 2024; .

PMID: 38370753 PMC: 10871260. DOI: 10.1101/2024.02.01.578450.


Intersectionality in Alzheimer's Disease: The Role of Female Sex and Black American Race in the Development and Prevalence of Alzheimer's Disease.

Misiura M, Butts B, Hammerschlag B, Munkombwe C, Bird A, Fyffe M Neurotherapeutics. 2023; 20(4):1019-1036.

PMID: 37490246 PMC: 10457280. DOI: 10.1007/s13311-023-01408-x.

References
1.
Bretsky P, Buckwalter J, Seeman T, Miller C, Poirier J, Schellenberg G . Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. Alzheimer Dis Assoc Disord. 1999; 13(4):216-21. DOI: 10.1097/00002093-199910000-00007. View

2.
Yamamoto N, Igbabvoa U, Shimada Y, Ohno-Iwashita Y, Kobayashi M, Wood W . Accelerated Abeta aggregation in the presence of GM1-ganglioside-accumulated synaptosomes of aged apoE4-knock-in mouse brain. FEBS Lett. 2004; 569(1-3):135-9. DOI: 10.1016/j.febslet.2004.05.037. View

3.
Seyfried T, Yu R . Ganglioside GD3: structure, cellular distribution, and possible function. Mol Cell Biochem. 1985; 68(1):3-10. DOI: 10.1007/BF00219383. View

4.
Fewlass D, Noboa K, Pi-Sunyer F, Johnston J, Yan S, Tezapsidis N . Obesity-related leptin regulates Alzheimer's Abeta. FASEB J. 2004; 18(15):1870-8. DOI: 10.1096/fj.04-2572com. View

5.
Chan S, Kim W, Kwok J, Hill A, Cappai R, Rye K . ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro. J Neurochem. 2008; 106(2):793-804. DOI: 10.1111/j.1471-4159.2008.05433.x. View